What changed between the resolution motion and the adopted text

Changed:P. whereas theCommission draftImplementing CommissionDecision implementing(EU) decision2026/1417 would continue to allow imports into the Union that do not comply with the standards observed by Union farmers, thereby placing them at a competitive disadvantage;

Changed:1. Considers that theCommission draftImplementing CommissionDecision implementing(EU) decision2026/1417 exceeds the implementing powers provided for in Regulation (EC) No 1829/2003;

Changed:2. Considers that theCommission draftImplementing CommissionDecision implementing(EU) decision2026/1417 is not consistent with Union law, in that it is incompatible with the aim of Regulation (EC) No 1829/2003, which is, in accordance with the general principles laid down in Regulation (EC) No 178/2002 of the European Parliament and of the Council, to provide the basis for ensuring a high level of protection of human life and health, animal health and welfare, and environmental and consumer interests, in relation to GM food and feed, while ensuring the effective functioning of the internal market;

Changed:A. whereas Commission Implementing Decision (EU) 2015/2279 authorised the placing on the market of food and feed containing, consisting of, or produced from genetically modified maize NK603 × T25 (‘GM(the ‘GM maize’); whereas the scope of that authorisation also covered the placing on the market of products other than food and feed containing or consisting of the GM maize, for the same uses as any other maize, with the exception of cultivation;

Changed:C. whereas on 27 November 2025, EFSA issued a favourable scientific opinion on the GM maize, in accordance with Articles 6 and 18 of Regulation (EC) No 1829/2003; whereas it concluded that the renewal application did not contain evidence of any new hazards, modified exposure or scientific uncertainties that would change the conclusions of the original risk assessment on the GM maize, adopted by the EFSA in 2015; whereas those opinions did not address several broader environmental, socio-economic, and cumulative impacts which EFSA considers to fall outside its remit;

Changed:D. whereas the GM maize is a stacked herbicide-tolerant genetically modified maize developed by combining the NK603 event (glyphosate tolerance) and the T25 event (glufosinate ammonium tolerance);

Changed:F. whereas the vast majority of GM crops, including the GM maize, have been genetically modified so that they are tolerant to one or more ‘complementary’ herbicides which can be used throughout the cultivation of the GM crop, without the crop dying, as would be the case for a non-herbicide tolerant crop; whereas a number of studies show that herbicide-tolerant GM crops result in a higher use of complementary herbicides, in large part because of the emergence of herbicide-tolerant weeds;

Changed:G. whereas herbicide-tolerant GM crops lock farmers into a weed management system that is largely or wholly dependent on herbicides, and does so by charging a premium for GM seeds while creating a dependency on the use of complementary herbicides as an integral part of the production system; whereas heightened reliance on the complementary herbicides on farms planting the GM maize will accelerate the emergence and spread of weeds resistant to those herbicides, thereby triggering the need for even more herbicide use, a vicious circle known as ‘the herbicide treadmill’; whereas, as a consequence, the adverse impacts stemming from excessive reliance on herbicides will worsen soil health, water quality, and above and below ground biodiversity, as well as leading to increased human and animal exposure, potentially also via increased herbicide residues on food and feed;

Changed:N. whereas Union renewal of the authorisation of the GM maize would not be consistent with international commitments on pesticide reduction, given the increased human, animal and environmental exposure to glyphosate and glufosinate in countries which grow this herbicide-tolerant GM crop, along with the potentially serious associated health outcomes;

Changed:O. whereas the cultivation of the GM maize is not allowed in the Union;

Changed:4. Calls on the Commission not to renew the authorisation of the GM maize due to the lack of sufficient evidence on long-term impacts on biodiversity, food safety, farmers’ livelihoods and animal health, in line with the One Health approach;